Clinical pharmacokinetics of adefovir in human immunodeficiency virus type 1-infected patients.
The pharmacokinetics and bioavailability of adefovir [9-[2-(phosphonomethoxy)ethyl]adenine] were examined at two dose levels in three phase I/II studies in 28 human immunodeficiency type 1-infected patients. The concentrations of adefovir in serum following the intravenous infusion of 1.0 or 3.0 mg/...
Kaydedildi:
| Yayımlandı: | Antimicrob Agents Chemother |
|---|---|
| Asıl Yazarlar: | , , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
American Society for Microbiology (ASM)
1995
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC162955/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/8585716/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.39.11.2401 |
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|